Remdesivir for COVID-19: Why Not Dose Higher?

被引:8
|
作者
Yan, Victoria C. [1 ]
Mueller, Florian L. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA
关键词
COVID-19; GS-441524; drug metabolism; prodrug; remdesivir;
D O I
10.1128/AAC.02713-20
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] To Determine the Efficacy of Remdesivir in Covid-19
    Hameed, A.
    Mehmood, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S42 - S42
  • [32] Correction to: Remdesivir: A Review in COVID-19
    Hannah A. Blair
    Drugs, 2023, 83 (14) : 1349 - 1349
  • [33] The safety of remdesivir for COVID-19 patients
    Chen, Hsien-Lin
    Chao, Chien-Ming
    Lai, Chih-Cheng
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (04) : 1910 - 1912
  • [34] Compassionate Use of Remdesivir in Covid-19
    Wu, Jiayuan
    Wu, Bin
    Lai, Tianwen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25):
  • [35] Remdesivir, COVID-19, and Clinical Outcomes
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (02)
  • [37] Remdesivir in hospitalized COVID-19 Patients
    Thiem, Helena
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2022, 27 (03): : 111 - +
  • [38] Covid-19: What now for remdesivir?
    Hsu, Jeremy
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [39] Inhaled remdesivir treatment for COVID-19
    Yang, C.
    Zhag, H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (10) : 788 - 790
  • [40] Why promoting a COVID-19 vaccine booster dose?
    Loubet, Paul
    Laureillard, Didier
    Martin, Aurelie
    Larcher, Romaric
    Sotto, Albert
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (06)